Cargando…

Initiating Insulin as Part of the Treating To Target in Type 2 Diabetes (4-T) Trial: An interview study of patients' and health professionals' experiences

OBJECTIVE: To explore patients' and health professionals' experiences of initiating insulin as part of the Treating To Target in Type 2 Diabetes (4-T) randomized controlled trial. RESEARCH DESIGN AND METHODS: Interviews were conducted with 45 trial participants and 21 health professionals...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenkins, Nicholas, Hallowell, Nina, Farmer, Andrew J., Holman, Rury R., Lawton, Julia
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945156/
https://www.ncbi.nlm.nih.gov/pubmed/20592050
http://dx.doi.org/10.2337/dc10-0494
_version_ 1782187194287390720
author Jenkins, Nicholas
Hallowell, Nina
Farmer, Andrew J.
Holman, Rury R.
Lawton, Julia
author_facet Jenkins, Nicholas
Hallowell, Nina
Farmer, Andrew J.
Holman, Rury R.
Lawton, Julia
author_sort Jenkins, Nicholas
collection PubMed
description OBJECTIVE: To explore patients' and health professionals' experiences of initiating insulin as part of the Treating To Target in Type 2 Diabetes (4-T) randomized controlled trial. RESEARCH DESIGN AND METHODS: Interviews were conducted with 45 trial participants and 21 health professionals and thematically analyzed. RESULTS: Patients were generally psychologically insulin receptive when approached to participate in the 4-T trial. Their receptiveness arose largely from their personal experiences observing intensifying prior treatments and deteriorating blood glucose control over time, which led them to engage with and accept the idea that their diabetes was progressive. Health professionals also fostered receptiveness by drawing on their clinical experience to manage patients' anxieties about initiating insulin. CONCLUSIONS: Previous studies may have overemphasized the problem of psychological insulin resistance and overlooked factors and treatment experiences that may promote insulin receptiveness among type 2 patients.
format Text
id pubmed-2945156
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-29451562011-10-01 Initiating Insulin as Part of the Treating To Target in Type 2 Diabetes (4-T) Trial: An interview study of patients' and health professionals' experiences Jenkins, Nicholas Hallowell, Nina Farmer, Andrew J. Holman, Rury R. Lawton, Julia Diabetes Care Original Research OBJECTIVE: To explore patients' and health professionals' experiences of initiating insulin as part of the Treating To Target in Type 2 Diabetes (4-T) randomized controlled trial. RESEARCH DESIGN AND METHODS: Interviews were conducted with 45 trial participants and 21 health professionals and thematically analyzed. RESULTS: Patients were generally psychologically insulin receptive when approached to participate in the 4-T trial. Their receptiveness arose largely from their personal experiences observing intensifying prior treatments and deteriorating blood glucose control over time, which led them to engage with and accept the idea that their diabetes was progressive. Health professionals also fostered receptiveness by drawing on their clinical experience to manage patients' anxieties about initiating insulin. CONCLUSIONS: Previous studies may have overemphasized the problem of psychological insulin resistance and overlooked factors and treatment experiences that may promote insulin receptiveness among type 2 patients. American Diabetes Association 2010-10 2010-06-30 /pmc/articles/PMC2945156/ /pubmed/20592050 http://dx.doi.org/10.2337/dc10-0494 Text en © 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Jenkins, Nicholas
Hallowell, Nina
Farmer, Andrew J.
Holman, Rury R.
Lawton, Julia
Initiating Insulin as Part of the Treating To Target in Type 2 Diabetes (4-T) Trial: An interview study of patients' and health professionals' experiences
title Initiating Insulin as Part of the Treating To Target in Type 2 Diabetes (4-T) Trial: An interview study of patients' and health professionals' experiences
title_full Initiating Insulin as Part of the Treating To Target in Type 2 Diabetes (4-T) Trial: An interview study of patients' and health professionals' experiences
title_fullStr Initiating Insulin as Part of the Treating To Target in Type 2 Diabetes (4-T) Trial: An interview study of patients' and health professionals' experiences
title_full_unstemmed Initiating Insulin as Part of the Treating To Target in Type 2 Diabetes (4-T) Trial: An interview study of patients' and health professionals' experiences
title_short Initiating Insulin as Part of the Treating To Target in Type 2 Diabetes (4-T) Trial: An interview study of patients' and health professionals' experiences
title_sort initiating insulin as part of the treating to target in type 2 diabetes (4-t) trial: an interview study of patients' and health professionals' experiences
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945156/
https://www.ncbi.nlm.nih.gov/pubmed/20592050
http://dx.doi.org/10.2337/dc10-0494
work_keys_str_mv AT jenkinsnicholas initiatinginsulinaspartofthetreatingtotargetintype2diabetes4ttrialaninterviewstudyofpatientsandhealthprofessionalsexperiences
AT hallowellnina initiatinginsulinaspartofthetreatingtotargetintype2diabetes4ttrialaninterviewstudyofpatientsandhealthprofessionalsexperiences
AT farmerandrewj initiatinginsulinaspartofthetreatingtotargetintype2diabetes4ttrialaninterviewstudyofpatientsandhealthprofessionalsexperiences
AT holmanruryr initiatinginsulinaspartofthetreatingtotargetintype2diabetes4ttrialaninterviewstudyofpatientsandhealthprofessionalsexperiences
AT lawtonjulia initiatinginsulinaspartofthetreatingtotargetintype2diabetes4ttrialaninterviewstudyofpatientsandhealthprofessionalsexperiences